Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(101)
•••
biorun
X
View Profile
View Bullboard History
Post by
biorun
on Jan 15, 2024 9:13am
Key development for sure
1. We asked for something to change, and strategic moves that would not only be smart in theory AND could be logically and practically implemented, AND create a clear and responsible pathway for
...more
(6)
•••
nevinvestor
X
View Profile
View Bullboard History
Comment by
nevinvestor
on Jan 15, 2024 9:13am
RE:RE:New Press Release - Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)
If we take a look at the past 60 days at Sirona it becomes clear that there is movement: - GlycoProteMim ( The Ingredient ) Trademark. - Launch of Sirona Laboratories
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(11)
•••
Transperance
X
View Profile
View Bullboard History
Comment by
Transperance
on Jan 15, 2024 8:20am
RE:New Press Release - Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)
My assessment is that this should benefit us all proportionally, I see no immediate risk for conflicts of interest. The profits made will be shared with the private financial partnerships though. It
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 15, 2024 8:16am
RE:New Press Release - Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)
It's an attempt to raise funds via a non-public subsidiary at a price level that is higher than SBM's public stock price. Still dilution.
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 15, 2024 7:28am
RE:RE:Sirona Laboratories !!! Brilliant Strategy
I do think this move will benefit SBM shareholders, possibly by a fair margin. Having said that, the main beneficiaries will be Howie, and those un-named "private equity funds" that Howie
...more
(10)
•••
BurningMoney5
X
View Profile
View Bullboard History
Comment by
BurningMoney5
on Jan 15, 2024 4:16am
RE:Sirona Laboratories !!! Brilliant Strategy
We know nothing!!! It is again a carrot which Howard is thrown in the middle!! And then again his bloody smiling face of the front-page of the new site..!
(6)
•••
nevinvestor
X
View Profile
View Bullboard History
Post by
nevinvestor
on Jan 15, 2024 2:42am
Sirona Laboratories !!! Brilliant Strategy
Finally they have done something right... They will sell their own product line under Sirona Laboratories, implementing GlycoProteMim and shake up the cosmetics market. By having their own brand, they
...more
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jan 15, 2024 2:28am
RE:New Press Release - Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)
Doesn't say anything about it being a spin out to favour existing shareholders. Wonder how they will organize it share wise -- if any change at all?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 15, 2024 1:00am
New Press Release - Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)
VANCOUVER, Canada, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is proud to introduce Sirona LaboratoriesTM - a wholly-owned subsidiary dedicated to maximizing the commercial potential of its breakthrough anti-aging skincare ingredient...
read article.
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 11, 2024 3:32pm
RE:RE:What the hell....
p.s. non-exclusive licensing of Glycoprotemim means a race to market for makers of anti-aging creams, unlike the 1067 deal where Abbvie has no incentive to move swiftly.
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 11, 2024 2:56pm
RE:What the hell....
Trademarking Glycoprotemim is the key. It signals co. has begun marketing it to interested parties. As it gets licensed to more and more makers of anti-aging creams it becomes a the must have
...more
(10)
•••
BurningMoney5
X
View Profile
View Bullboard History
Comment by
BurningMoney5
on Jan 11, 2024 2:26pm
RE:RE:What the hell....
Give me one valid argument how Sirona will bring TFC-1326 into consumer and dermatologists without any experiences in that field and cash??? This is ridiculous!! The whole management is a disaster
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Jan 11, 2024 12:08pm
Continued selling on low volume
All that says is that no one really belives anything this management says anymore. Unfortunate that this state of non-events continues. JMO
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jan 11, 2024 10:42am
RE:What the hell....
All this activity says to me is that they are mobilizing resources in a cost effective way to move TFC 1326 to market while they wait for 1067 to hit the shelves and some entity decides to acquire TFC
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >